FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
Modifiable risk factors tied to young-onset dementia
Dec 28, 2023
Some of the factors include social isolation, diabetes, heart disease, vitamin D deficiency, high C-reactive protein and low handgrip strength.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.
ED visit rate 72.2 per 1,000 adults with diabetes in 2020 to 2021
Dec 20, 2023
The researchers found that the emergency department visit rate by adults with diabetes was 72.2 per 1,000 adults in 2020 to 2021, and the rate increased with age.
Your favorite columns of 2023
Dec 20, 2023
Assisted living regulation, government relations, ageism and pop culture, solutions for the middle market, and chronic disease and resident care were some of the column topics that especially grabbed the...
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Replacing sitting for a few minutes of activity each day shows health benefits
Dec 13, 2023
30 extra minutes of moderate-to-vigorous physical activity was tied to drops in body mass index.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Focus on briefs: Technology
By
John Hall
Dec 03, 2023
AI model enables earlier detection of diabetes through chest X-rays, Robots, virtual reality increasingly enhance senior living experiences
Lipid-lowering drugs save lives, but use decreasing
Dec 01, 2023
In 2019 to 2020, 56% of patients with high cholesterol were on statins for primary prevention and 85% were on them for secondary prevention.